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The initiation of programmed cell death at CD95 (Fas,
Apo-1) is achieved by forming a death-inducing signal-
ing complex (DISC) at the cytoplasmic membrane sur-
face. Assembly of the DISC has been proposed to occur
via homotypic interactions between the death domain
(DD) of FADD and the cytoplasmic domain of CD95. Pre-
vious analysis of the FADD/CD95 interaction led to the
identification of a putative CD95 binding surface within
FADD DD formed by  helices 2 and 3. More detailed
analysis of the CD95/FADD DD interaction now demon-
strates that a bimodal surface exists in the FADD DD for
interaction with CD95. An expansive surface on one side
of the domain is composed of elements in  helices 1, 2,
3, 5, and 6. This major surface is common to many pro-
teins harboring this motif, whether or not they are as-
sociated with programmed cell death. A secondary sur-
face resides on the opposite face of the domain and
involves residues in helices 3 and 4. The major surface is
topologically similar to the protein interaction surface
identified in Drosophila Tube DD and the death effector
domain of hamster PEA-15, two physiologically unre-
lated proteins which interact with structurally unre-
lated binding partners. These results demonstrate the
presence of a structurally conserved surface within the
DD which can mediate protein recognition with homo-
and heterotypic binding partners, whereas a second sur-
face may be responsible for stabilizing the higher order
complex in the DISC.
The subgroup of tumor necrosis factor receptor (TNFR)1 su-
perfamily members that contain a death domain (DD) within
their cytoplasmic region have been termed “death receptors”
(1). The receptor DD is the nucleus of an intracellular death-
inducing cellular signaling complex (DISC), which forms in
response to ligand binding by the receptor. The DISC of CD95
(Fas, Apo-1), one of six TNFRs that initiate cell death, is com-
posed of the activated receptor (2, 3), the adaptor protein FADD
(4, 5), and the initiator caspases, caspase-8 (6–8) and
caspase-10 (9, 10). A key molecule in this assembly is FADD,
which links the death receptor to the caspases, a function
attributed to FADD at nearly all death receptors identified to
date (1). FADD contains two 90-amino acid protein interac-
tion modules, an N-terminal death effector domain (DED), and
a C-terminal DD, each of which adopts a structurally similar
six -helical bundle (11–13). It has been suggested that the two
domains of FADD function independently of each other (4, 5),
with the DD responsible for interaction with CD95 and the
DED responsible for the subsequent recruitment of caspases
into the DISC (11–13).
Despite knowledge of the three-dimensional structures of the
DD (12–17) and DED (11, 18) motifs from a variety of proteins,
the mechanism of protein recognition by these structurally
homologous motifs has not been clearly defined. The crystal
structure of Drosophila Tube DD bound to the DD from the
serine/threonine kinase Pelle demonstrated that the DD motif
possessed two distinct and opposing protein interaction sur-
faces within their folded domains (16). One surface (the “loop
surface”) is formed principally by an interhelical loop and the
adjacent 1–2 turns of  helix found at the junction of helices 1
and 2 and helices 5 and 6, as exemplified in Tube DD (Fig. 1).
The second surface, exemplified by Pelle DD, is formed by 
helices 3 and 4 and the loop connecting helices 4 and 5, all
located on the opposite side of the motif relative to the “loop
surface” (Fig. 1). Remarkably, although the DD fold is highly
conserved, characterization of the homologous domains found
in the cell death proteins FADD (12, 19), CD95 (14), and
TRADD (20) all suggested a binding surface for their partners
that diverged from Tube and Pelle. Thus, it was conceivable
that apoptotic proteins harboring a DD motif might utilize the
domain in a unique fashion relative to those proteins which are
involved in other signaling pathways, such as Tube and Pelle.
Furthermore, the relatively low pairwise sequence identity be-
tween DDs seemed consistent with the notion of divergent
protein-protein interaction mechanisms for the same overall
three-dimensional structure.
We recently demonstrated that the DED of the phosphopro-
tein enriched in astrocytes, PEA-15, utilizes a Tube-like sur-
face for interaction with its binding partner, the extracellular
signal-regulated kinase mitogen-activated protein mitogen-ac-
tivated protein kinase (Ref. 18; Fig. 1). The topological similar-
ity in the DD and DED motif interactions in these two cases
prompted a reexamination of the protein recognition mecha-
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nism(s) involving these motifs among apoptotic factors. Char-
acterization of a panel of mutants introduced into the DD of
FADD, in the context of the full-length protein, now demon-
strates that the FADD DD interaction with the cytoplasmic
domain of CD95 is also related to the protein interaction mech-
anism employed by Tube DD. The loop surface in FADD DD is
extended further into  helix 2 and  helix 3 relative to Tube
DD. In addition, a small patch of positively charged residues
residing in helices 3 and 4, on the opposite face of the domain
from the loop surface, also display reduced binding to CD95.
Thus, FADD recruitment into the DISC may be bimodal. Mu-
tations across the CD95 interaction surface substantially re-
duce the relative cell-killing activity of FADD in cell culture,
consistent with the reduced affinity of mutant FADD proteins
for CD95 in reconstitution experiments. Immunoprecipitation
of CD95 DISCs under these conditions demonstrates that re-
duced cell killing of mutant FADD in culture is caused by a
reduced ability of mutant FADD to assemble the CD95 DISC.
These results suggest an alternative view from which protein
recognition by the DD of cell death-associated proteins may be
understood, namely, that the binding surface of a DD for an
apoptotic partner is topologically conserved with that of non-
apoptotic proteins harboring structurally related motifs. The
diversity in protein recognition mechanisms by the DD and
DED motifs is thus achieved by the expansion of a core, con-
served interaction surface to distinguish functionally diverse
binding partners.
MATERIALS AND METHODS
Proteins and DNAs—cDNA of full-length human FADD was inserted
into pET-28b (Novagen) and specific amino acid mutations were gener-
ated with the QuikChange site-directed mutagenesis kit (Stratagene).
Mutants of FADD were constructed in which surface-exposed residues
(identified by inspection of the individual domain structures; Refs. 12
and 13) were substantially altered in side chain length and/or charge,
while minimizing the likelihood of altering the protein structure. The
resulting mutations were confirmed by DNA sequencing. Wild-type and
mutant FADDs were expressed in vitro using the TNT T7 coupled
reticulocyte lysate system (Promega) in the presence of [35S]methi-
onine. The intracellular domain of human CD95 was overexpressed as
a GST fusion protein using a pGEX-6P-1 vector (Amersham Bio-
sciences) and batch purified on glutathione agarose beads (Sigma). An
enforced trimer of the CD95 cytoplasmic domain was constructed using
a trimeric coiled coil (21) fused to residues 178–304 of CD95 in the
pQE-30 vector (Qiagen). The overexpressed fusion protein was purified
under denaturing conditions using Ni2-affinity chromatography. Re-
folding was initiated by dilution of the purified protein into 6 M guani-
dine hydrochloride (GnHCl), 50 mM Tris-HCl, pH 8.0, 500 mM NaCl, 2
mM dithiothreitol, 5% glycerol (v/v) at a final protein concentration of
0.2–0.4 mg/ml, followed by stepwise dialysis to 2 M GnHCl over 12 h,
then 0 M GnHCl over 12 h at 4 °C in the same buffer. The refolded
protein was concentrated to 1–2 mg/ml and fractionated by preparative
size-exclusion chromatography using Superdex-75. The eluted protein
appears as a symmetrical peak and is judged to be homogenously
trimeric based on the calibrated elution volume from the column. For
immunofluorescence, cell viability, and co-immunoprecipitation exper-
iments, human FADD was inserted into pcDNA 3.0 (Invitrogen) with a
hemagglutinin (HA) tag at the C terminus.
In Vitro Protein Interaction Assay—GST-CD95 intracellular domain
was mixed with wild-type FADD or mutant FADD in a 150 l solution
containing 50 mM HEPES-KOH, pH 7.4, 50 mM NaCl, 0.1% Nonidet
P-40, 5 mM EDTA, and 10% glycerol (w/v). Binding was conducted at
4 °C for 2 h. The bound complex was washed three times with 500 l of
the same buffer and the proteins eluted with SDS-PAGE loading dye,
separated by 16% Tricine SDS-PAGE, and visualized by phosphorim-
aging. For trimeric CD95, the protein was immobilized on Ni2-agarose,
and pull-down experiments with FADD were performed in a 150 l
solution containing 50 mM HEPES-KOH, pH 7.4, 50 mM NaCl, 0.1%
Nonidet P-40, 10% glycerol, and 70 mM imidazole as described above.
Cell Viability Assay—Cell viability was measured in triplicate be-
tween 12 and 24 h after transfection with pcDNA 3.0 harboring either
wild-type FADD or mutant FADD. 200 ng of FADD plasmid DNA was
co-transfected with 20 ng of plasmid harboring GFP into MCF7-Fas
cells (22) and incubated for 6 h; apoptosis was induced by the addition
of an aggregating anti-Fas antibody (CH11, Upstate Biotechnology).
Cell morphology was followed by GFP fluorescence, and chromatin
condensation was followed by Hoechst staining of cells. Approximately
100 GFP-positive cells were counted in triplicate to determine the
relative rate and extent of cell death in the presence or absence of
anti-CD95 treatment.
Immunoprecipitation—For co-immunoprecipitation with anti-Fas,
MCF7-Fas cells were transfected with 4 g of either wild-type FADD or
mutant FADD. For DISC assembly, anti-CD95 antibody (APO-1–3,
Kamiya Biomedical) was added to the media 6 h after transfection and
incubated at 37 °C for 5 min. Cells were lysed on ice with immunopre-
cipitation binding buffer (30 mM Tris-HCl, pH 7.5, 150 mM NaCl, 2 mM
EDTA, 1 mM phenylmethylsulfonyl fluoride, protease inhibitors mix-
ture (Roche Applied Science), 1% Triton X-100, and 10% glycerol) for 30
min. The lysate was spun at 14,000  g for 15 min. Protein A magnetic
beads (New England Biolabs) were added to the lysate and incubated
for another 3 h. Beads were washed three times with IP buffer. After
SDS-PAGE, the proteins were blotted onto nitrocellulose membrane for
immunodetection and probed with anti-HA antibody (3F10, Roche Ap-
plied Science). As a negative control, MCF7-Fas cells transfected with a
vector expressing wild-type FADD-HA were lysed 6 h after transfection,
and anti-CD95 was added for 5 min at the end of the lysis period but
prior to immunoprecipitation with protein A magnetic beads.
NMR Spectroscopy—1H-15N heteronuclear single quantum coher-
ence (HSQC) spectra were collected for the individual domains of FADD
containing single point mutants defective for CD95 binding. FADD DD
(residues 89–183) was cloned into pQE-9 (Qiagen), which produced the
recombinant protein domain with a His6 sequence at the N terminus.
FIG. 1. Conserved protein-interaction surfaces of death do-
mains and death effector domains. Backbone representations of the
Tube DD (a) (16), Pelle DD (b) (16), and PEA-15 DD (c) (18) are shown
in blue, with residues important for binding their target proteins high-
lighted in red. The two principle binding surfaces are the loop surface
composed of residues in the interhelical loop and adjacent turns of 
helix between helices 1 and 2, as well as helices 5 and 6. The second
surface resides principally in  helix 4 on the opposite side of the motif
relative to the loop surface, as exemplified in Pelle.
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15N-labeled proteins were produced on a small scale in shake flasks and
purified with Ni2-affinity chromatography. NMR samples contained
0.3 mM protein in 50 mM potassium phosphate buffer, pH 6.2, 150 mM
NaCl, 1 mM dithiothreitol, and 50 M NaN3 for FADD DD. Two-dimen-
sional 1H-15N HSQC spectra of the mutant proteins were compared
with those of the wild-type DD to establish that the mutant proteins
possessed the same overall three-dimensional structure.
RESULTS
Identification of the FADD DD Binding Surface for
CD95—To elucidate the mechanism of FADD recruitment to
CD95, site-directed mutagenesis was used to identify function-
ally important residues within the FADD DD that are involved
in binding to the receptor cytoplasmic domain. Mutants were
constructed in which surface-exposed residues were substan-
tially altered in side-chain length and/or charge while minimiz-
ing the likelihood of altering the protein structure. Character-
ization of these mutants by GST-pull-down assay with the
intracellular domain of CD95 (GST-CD95IC) revealed a bind-
ing surface for CD95 that traverses all six  helices of the
FADD DD (Fig. 2 and Table I). Residues within  helices 1
(D106R), 2 (R113E, R117E), 3 (D123R), 5 (R166E), and 6
(L172E, D175R) as well as the helix 5–6 loop (Q169A) of FADD
DD all contribute to CD95 binding on one face of the domain
(Fig. 2, a–c). An additional set of mutants in helices 3 (K125A)
and 4 (R142A/E, R146A) were also shown to be defective for
CD95 interaction in a GST pull-down assay.
Activated CD95 in cells is most likely trimeric; thus, it may
be reasonably questioned whether GST-CD95IC immobilized
on agarose beads appropriately represents the cellular state of
the activated receptor. To mimic the trimeric receptor, an “ar-
tificial receptor” was created by fusing CD95IC C-terminal to a
peptide known to form a trimeric coiled-coil (21). The trimeric
“artificial” receptor was purified to homogeneity by size-exclu-
sion chromatography, which ensured that a well defined trimer
of the CD95 cytoplasmic domain had been created. This artifi-
cial receptor was then used to probe the FADD DD mutants
using an Ni2-affinity bead pull-down assay. FADD DD mu-
tants that failed to bind GST-CD95 also failed to bind trimeric
TABLE I
Mutagenesis of FADD within the death domain
Mutation Activitya Foldb
E95R c NT
A99E  NT
D106A  Native
R113E  Native
R117E  Native
D123R  Native
K125A  Native
E139R  NT
R142A  Native
R142E  NT
R146A  Native
E152A  NT
R166E  Native
Q169A  Native
L172E  Native
D175R  Native
a Activity determined by quantitation of band intensity in a GST-
pulldown assay relative to a GST-only control.
b Fold determined by similarity in peak pattern of 15N-1H HSOC
spectra of N-terminally hexahistidine-tagged FADD DD (residues 89–
183) mutant compared to wildtype.
c ,50% of wildtype;, 10–50% wildtype;,10% wildtype; NT,
not tested.
FIG. 2. Identification of the FADD DD binding surface for CD95. a, site-directed mutagenesis of surface-exposed residues in FADD DD (in
the context of the full-length protein) reveals residues within  helices 1 (D106A), 2 (R113E, R117E), 3 (D123R), 5 (R166E), and 6 (L172E, D175R),
as well as the helix 5–6 loop (Q169A) that contributes to CD95 binding. In addition to those shown, mutants in helix 1 (E95R and A99E) and helix
4 (E139R, E152A) were also tested in a GST pull-down and found to be similar to wild-type. The relative binding efficiency of FADD or FADD
mutant to a GST-CD95 intracellular domain fusion protein (GST-CD95IC) is nearly identical to that of an activated CD95 receptor mimic (trimer
CD95IC) created by fusing the intracellular domain of CD95 to a trimeric coiled-coil (21). These results suggest that domain-to-domain interaction
between FADD and CD95 is not influenced by the oligomeric state of the receptor. b, binding-defective DD mutants mapped onto the three-
dimensional structure of FADD DD (13). All of these CD95 binding-deficient mutants (red) reside on one face of the domain. Those mutants that
did not affect CD95 binding in a GST pull-down assay are colored green. c, additional binding-defective mutants from a, which reside on the
opposite face of the FADD DD relative to those in b, are highlighted in red. This view of the FADD DD is rotated 60° clockwise around the y axis
relative to the view in b.
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CD95 (Fig. 2a), displaying a nearly identical binding profile for
trimeric CD95 as that observed for the GST-fusion protein.
FADD DD Mutants Retain Their Structural Integrity—Be-
cause the mutation strategy substantially altered the physical
property of the native amino acid at any mutated position, each
mutant protein was analyzed by 15N-1H NMR correlation spec-
troscopy to determine whether the protein structure had been
altered by the mutation. The pattern of NMR crosspeaks in the
mutant protein NMR spectra were similar to that of the native
DD, with only minor changes in the peak pattern observed in
each case (Fig. 3). These data demonstrate that the CD95
binding-defective mutants of FADD most likely possessed a
native-like three-dimensional fold. Thus, the loss in binding by
any FADD mutant in a pull-down experiment was due to a
reduction in binding affinity for CD95 as a consequence of
the mutation.
Functional Analysis of FADD DD Mutant Proteins in MCF7-
Fas Cells—To confirm the physiological relevance of reduced
FADD binding to CD95 in a pull-down assay, the FADD DD
mutants that exhibited reduced CD95 association in vitro were
expressed in MCF7-Fas cells and tested for their ability to
induce apoptosis in cell culture (Fig. 4). A plasmid expressing
FADD or FADD mutant fused to an HA tag was transfected
into MCF7-Fas cells, and the cells were subsequently stimu-
lated at the CD95 receptor with an aggregating antibody
known to activate the receptor. The time course of cell death
was then followed, as determined by characteristic changes in
cell morphology and chromatin condensation (Fig. 4). As a
control experiment, the effect of FADD overexpression in the
absence of receptor stimulation was followed under identical
conditions. In unstimulated cells, the rate and extent of cell
death in the presence of overexpressed FADD were quite mod-
est during the first 24 h after transfection and mirror the effect
of transfection with the pcDNA vector itself (Fig. 4, a and b).
Thus, FADD overexpression, at the level employed in this
study, is inefficient at inducing cell death in the absence of an
apoptotic stimulus of these cells. By contrast, stimulation of
CD95 after transfection with a FADD expression vector re-
sulted in the death of 80% of the culture within 24 h (Fig. 4,
c and d). The mutant FADD proteins display a differential
ability to support stimulated cell death. D106A, R113E, and
D175R are among the most deficient mutants and fail to dis-
play a pull-down with either GST-CD95IC or trimer CD95IC.
Q169A, on the other hand, is similar to wild type in its relative
cell-killing ability, which mirrors the minor reduction of Q169A
binding seen in the pull-down assays. For those residues form-
ing a small positive patch on a secondary surface, the correla-
tion of the pull-down and cell viability data is less clear. Both
K125A and R142A fail to show a pull-down response, but
K125A is quite similar to Q169A in terms of its effect on cell
killing. For this reason, it is possible that the positive patch
formed by Lys125, Arg142, and Arg146 may play a secondary
role in the assembly of the signaling complex. Clearly the effect
of the mutants is more graded in cultured cells (Fig. 4c) relative
to the all or nothing response observed by the in vitro pull-down
experiment (Fig. 2a). This is most likely caused by the exten-
sive washing of the FADD-loaded CD95IC beads in the pull-
down, which could wash away all but the most able CD95
binding mutants of FADD. The relative cell-killing ability of
the overexpressed FADD proteins in cell culture was not a
consequence of differential expression of FADD or FADD mu-
tants. Western blot analysis of cell extracts (Fig. 4a, Inset)
demonstrates that the wild-type and mutant proteins were
expressed at nearly equal levels in these cells.
To further demonstrate the role of FADD DD residues in
CD95 interaction, MCF7-Fas cells were activated in the pres-
ence of overexpressed wild-type or mutant FADD, and the
DISCs were subsequently isolated by anti-CD95 immunopre-
cipitation (DISC IP), while the majority of the cells were still
alive (Fig. 5). The precipitated proteins were then visualized by
anti-HA Western blot to view the relative levels of wild-type or
mutant FADD in the CD95 DISC (Fig. 5). DISC IP confirmed
the results seen in vitro, namely, that the mutant FADD pro-
teins inefficiently associate with CD95. A control experiment in
which anti-CD95 was added after lysis of the cells failed to
immunoprecipitate FADD, indicating that the reduced associ-
FIG. 3. Site-directed mutants of FADD DD are structurally
similar to the wild-type protein. 15N-1H HSQC spectra of wild type
(black) and mutant FADD DD (red) are nearly identical for D106A,
R113E, D123R, K125A, R142A, R146A, R166E, and D175R. NMR spec-
tra of the wild-type and mutant DDs were collected at 25 °C in 50 mM
potassium phosphate buffer, pH 6.2, 150 mM NaCl, and 1 mM dithio-
threitol. Although there are a few shifted peaks in each mutant spec-
trum shown, these are most likely the consequence of the change in a
locally charged surface. All of the mutant spectra (red) are well dis-
persed and display an overall pattern of peaks consistent with the fold
of the wild-type protein domain (black). The peak corresponding to the
residue mutated in the wild-type protein is indicated by the
green arrow.
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ation of mutant FADD into the DISC was specific to complex
assembly. The correlation between the binding affinity of the
FADD mutants both in vitro and in vivo and the pro-apoptotic
potential of these mutants in MCF7-Fas cells confirms that the
CD95-binding surface was identified in the pull-down assays.
DISCUSSION
The death motif superfamily, composed of the DD, DED, and
caspase recruitment domain (CARD), are the primary media-
tors of protein-protein interactions required for the transmis-
sion and regulation of apoptotic signals (23). Commensurate
with the importance of elucidating the molecular basis and
specificity of death motif interactions, numerous structural and
mutagenesis studies of individual domains have been under-
taken (11–15, 17–20, 24, 25), and x-ray crystal structures have
been determined for heterodimer complexes formed by the
CARDs of Apaf-1 and procaspase-9 (26) and the DDs of Dro-
sophila Tube and Pelle (16). However, no common protein
interaction surfaces have been revealed from these studies as
the residues that form the interface are dramatically different
between these two heterodimer structures; they also differ
from the surfaces suggested by mutagenesis to mediate other
death motif interactions.
In this study, functional characterization of FADD DD mu-
tants has revealed that an extensive surface spanning ele-
ments in all six  helices in the domain is required for CD95
interaction. Pull-down assays using either GST-CD95IC or a
trimeric-receptor mimic demonstrate that this extended sur-
face is responsible for the association of FADD DD with CD95
(Fig. 2). Mutants that demonstrated reduced binding efficiency
in pull-down assays were deficient at supporting apoptosis and
displayed reduced recruitment into the CD95 DISC in MCF7-
Fas cells. To minimize the potential interference from endoge-
FIG. 4. CD95 binding defective mutants of FADD display reduced apoptosis in MCF7-Fas cells. The rate and extent of apoptosis were
followed by analysis of cell morphology and chromatin condensation at the indicated times. Approximately 100 cells were counted for each mutant
at each time point in triplicate. Standard deviations have been excluded for clarity, but they vary between 3–9%. a, unstimulated MCF7-Fas cells
were transfected with wild-type or mutant full-length FADD harboring a single mutation at the indicated position in the FADD DD. Transfected
cells were identified by GFP fluorescence and counted based on the morphology of the cell and the appearance of the nuclei after Hoechst staining.
In the absence of a stimulus, the rate and extent of cell death induced by overexpression of FADD are essentially equivalent to that of transfection
with the pcDNA vector control, indicating that the overexpression of FADD or FADD mutant is inefficient at inducing apoptosis in the absence of
receptor stimulus. Inset, an anti-hemagglutinin Western blot of the expression level of FADD or FADD mutant in unstimulated cells, demon-
strating that the observed effects are not the consequence of differential expression of the proteins. Actin was used as a loading control (not shown).
D106A, K125A, and R142A all expressed at levels approximately equal to those of wild type (not shown). b, an example of the scoring of cell counts
is shown for transfected, wild-type FADD with a C-terminal hemagglutinin tag (FADD-HA) at the 24-h time point. Both cell morphology and
Hoechst staining demonstrate that the cells are essentially unaffected by overexpression of FADD in the absence of CD95 activation. c, in cells
stimulated at the CD95 receptor by an aggregating antibody (see “Materials and Methods”), rates of cell death are impaired for mutant FADD
which displayed reduced association with GST-CD95 or a trimeric CD95-receptor mimic in a pull-down assay (Fig. 2a). The relative efficiency of
the FADD mutants to induce apoptosis in cell culture mirrors the relative ability of mutant FADD to associate with CD95 in a pull-down assay.
Standard deviations have been excluded for clarity, but they vary between 3–9% (see “Supplemental Material”). d, representative scoring of cell
death after 24 h overexpression of wild-type FADD-HA in receptor-stimulated MCF7-Fas cells. Both the rounded cell morphology and Hoechst
staining of shrunken nuclei (indicated by arrowheads) demonstrate that FADD-HA overexpression efficiently kills the cells by apoptosis after
receptor stimulation.
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nous FADD in these experiments, MCF7-Fas cells were stim-
ulated 6 h after transfection. At this time, the overexpressed
FADD protein was clearly discernable by immunofluorescence
microscopy, indicating that the level of overexpressed protein
greatly exceeds that of the endogenous FADD and should com-
pete effectively with the endogenous protein for CD95 binding
sites. A potential issue in this approach is the effect of FADD
overexpression on the analysis of apoptotic signaling in cell
culture. If overexpressed FADD can kill the cells by a CD95-
independent mechanism, then our measurement of relative
cell-killing ability would not report on the efficiency of CD95
DISC formation. However, it was observed that MCF7-Fas cells
are insensitive to FADD overexpression unless the receptor is
stimulated. The morphologic changes observed in these cells
upon receptor stimulation (Fig. 4) are consistent with previous
reports (see, for example, Ref. 27). Our results contrast an
earlier observation in which overexpression of FADD in CrmA-
modified MCF7 cells induced morphologic changes consistent
with apoptosis in the absence of a receptor stimulus (5). We can
only presume that the CrmA-modified cells contained other
uncharacterized defects, making these cells highly sensitive to
overexpression of FADD. Alternatively, FADD aggregation
may have activated caspases-8 and -10 inside the CrmA-mod-
ified cells as a consequence of the 5-fold higher level of plasmid
used for transfection of the CrmA-modified cells relative to that
employed in Fig. 4. Aggregation and subsequent activation of
DISC components as a consequence of very high levels of over-
expression is well known to induce cell death (28). Given that
the overexpressed proteins in this report did not induce apo-
ptosis in the absence of a stimulus and that the behavior of
these mutants in cell culture approximately correlates with the
behavior of wild-type and mutant FADD in reconstitution ex-
periments, it is reasonable to assume that overexpression in
this instance did not significantly influence the identification
of the FADD DD binding surface.
Site-directed mutagenesis of the DDs of FADD (12, 19),
CD95 (14), TNFR1 (25), and the TNFR1-associated death do-
main protein (20) previously implicated  helices 2 and 3 in the
mutual interaction of receptor DD with effector DD. These
observations were contrasted by the interaction mechanism
observed in the crystal structure of a DD complex formed
between Drosophila Tube and Pelle (16), in which  helices 2
and 6 and the helix 5–6 loop of Tube DD interacted with 
helices 3 and 4 of Pelle DD. The disparity in the apparent
interaction mechanism of CD95/FADD versus Tube/Pelle sug-
gested that the DD may be a promiscuous protein-protein in-
teraction module with multiple potential sites for engaging its
binding partners (16, 23). In contrast to this hypothesis, we
have shown that the CD95 binding surface within the DD of
FADD extends beyond  helices 2 and 3 and is topologically
similar to the Pelle-interaction surface of Tube DD (Fig. 6).
FADD DD engages CD95 with the loop surface first identified
in Tube DD but extends this surface into helices 2 and 3 on the
same side of the motif. Similar regions within the two DEDs of
MC159, a viral caspase-8 inhibitory protein, have also been
implicated in the ability of MC159 to engage its binding part-
ners (29). The relationship between the protein interaction
surfaces suggested for the Fas/FADD interaction and the
Tube/Pelle interaction is not limited to the interaction be-
tween the DD and a partner harboring a homologous motif.
Heterologous binding partners for the DED can also follow
the Tube/Pelle paradigm, exemplified by the interaction be-
tween the phosphoprotein enriched in astrocytes, PEA-15,
and extracellular signal-regulated kinase mitogen-activated
protein kinase (18). Remarkably, PEA-15 DED employs a
Tube-like surface to engage a binding partner with neither
sequence nor structural similarity to a DD or DED motif (18).
The observation of topologically similar binding surfaces in
the FADD DD, the DEDs of MC159, PEA-15 DED, and Tube
DD argues strongly that protein-protein interactions medi-
ated by the DD or DED motif likely occur by a common
mechanism.
All three members of the death motif superfamily (DD, DED,
and CARD) possess a similar three-dimensional structure with
a common hydrophobic core (30). The DD and DED can be
distinguished from one another on the basis of their amino acid
sequences, but functionally they appear to be quite similar
(Fig. 6). The DED of PEA-15 (18) and the DD of FADD use a
topologically conserved surface to interact with their respective
binding partners (Fig. 6a). However, the x-ray structure of the
Apaf-1/procaspase-9 CARD complex (26) revealed that the
CARD may function differently from DD/DED because of
the presence of a severely kinked helix 1. Procaspase-9 employs
the kink in helix 1, along with helix 4, to interact with residues
in helices 2 and 3 of Apaf-1 (Ref. 26; Fig. 6b). This arrangement
of CARD-CARD interactions diverges from the DD-DD inter-
actions in Tube/Pelle and is inconsistent with the view of the
PEA-15 DED (12, 18, 19, and this study; Fig. 6b). FADD DD
appears to follow the Tube/Pelle paradigm, with an extension of
the loop surface into helices 2 and 3 on the same face of the
domain. The inclusion of the loop surface as part of the FADD
DD interaction surface for CD95 suggests that a CD95/FADD
complex will most likely form by a Tube/Pelle-like mechanism
at the level of domain-to-domain recognition. This viewpoint is
supported by structural and mutagenesis data for homotypic
(Refs. 12 and 19, and this study) and heterotypic (18) interac-
tions involving the DD or DED. However, the interaction of
FADD with CD95 in the DISC is likely to be more complex than
one suggested by consideration of domain-to-domain interac-
FIG. 5. Immunoprecipitation of mutant CD95 DISCs demon-
strates that mutant FADD inefficiently associates with CD95 in
vivo. Anti-CD95 immunoprecipitation was initiated 6 h after transfec-
tion of MCF7-Fas cells with an expression plasmid for FADD or FADD
mutant. Cultured cells were stimulated for 5 min with anti-CD95 fol-
lowed by immunoprecipitation, as described under “Materials and
Methods.” The precipitated DISCs were then probed with an anti-HA
antibody to visualize the wild-type or mutant-overexpressed FADD
associated with the activated receptor. The time point of immunopre-
cipitation was chosen such that 90% of the cells in culture were alive.
The reduced association of the mutant FADDs relative to wild type
demonstrates that the reduced cell-killing ability of mutant FADD (Fig.
4) is a consequence of inefficient assembly of activated receptor DISCs.
The cont lane indicates the addition of anti-CD95 after cell lysis of
unstimulated cells for 5 min before immunoprecipitation. As expected,
very little FADD-HA is immunoprecipitated by anti-CD95 in this con-
trol experiment, as no DISCs would have been present.
FADD Interaction Surface for CD95 1479
 at UQ Library on October 11, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
tions alone. Structurally homologous residues in helices 2 and
3 of FADD DD and Apaf-1 CARD are also apparently involved
in the interaction with a binding partner in each case (Fig. 6b).
The same can be said for residues in helix 4 (i.e. Arg142 and
Arg146) of FADD DD and caspase-9 CARD (Fig. 6b). Thus,
FADD DD may engage CD95 with a hybrid set of interactions
composed of Tube/Pelle and Apaf-1/procaspase-9 modes. One
plausible hypothesis may be that Tube/Pelle-like interactions
are used for domain-to-domain recognition, and CARD-like
interactions help to establish the higher order complex. An
intriguing model of the CD95/FADD complex (31) suggests that
the DISC is assembled as a 3:3 complex of FADD and CD95 in
which the Tube/Pelle and Apaf-1/procaspase-9 modes are jux-
taposed, forming Tube/Pelle and Apaf-1/procaspase-9-like in-
terfaces to assemble a higher order complex. The mutants in
FADD DD at positions 125, 142, and 146 would seem to support
a juxtaposition of these two binding modes in the DISC. Deter-
mination of the stoichiometry of these proteins in the complex
will be required to further elaborate this model of DISC
assembly.
Acknowledgments—We thank Vishva Dixit, Michael Lenardo, and
Marcus Peter for cDNAs of human CD95, FADD, and caspase-8, and
Marcus Peter for MCF7-Fas cells, antibodies, and many useful
discussions.
REFERENCES
1. Ashkenazi, A., and Dixit, V. M. (1998) Science 281, 1305–1308
2. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M.,
Hase, A., Seto, Y., and Nagata, S. (1991) Cell 66, 233–243
3. Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber,
M., Richards, S., Dhein, J., Trauth, B. C., Ponsting, H., and Krammer, P. H.
(1992) J. Biol. Chem. 267, 10709–10715
4. Boldin, M. P., Varfolomeev, E. E., Pancer, Z., Mett, I. L., Camonis, J. H., and
Wallach, D. (1995) J. Biol. Chem. 270, 7795–7798
5. Chinnaiyan, A. M., O’Rourke, K., Tewari, M., and Dixit, V. M. (1995) Cell 81,
505–512
6. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V., and Wallach, D. (1996) Cell 85,
FIG. 6. Conservation of protein-interaction surfaces for the death domain and death effector domain. a, backbone representations
(blue) of the three-dimensional structures of FADD DD (12–13), PEA-15 DED (18), and Tube DD (16,) with the residues implicated in forming the
protein-interaction surface highlighted in red. The two-helix insert in Tube DD relative to the others has been excluded for clarity (16). For PEA-15
DED and Tube DD, the contact surface for their respective binding partners involves nearly identical segments of the three-dimensional structure.
FADD DD shares many of the elements of its interaction surface with PEA-15 DED and Tube DD but extends this surface into helices 2 and 3 on
the same side of the domain. b, structure-based sequence alignment of the FADD DD, PEA-15 DED, Tube DD, Pelle DD, Apaf-1 CARD, and
procaspase-9 CARD. The alignment was performed by a pair-wise structure-based alignment using DALI, in which each protein was fit to FADD
DD (32). The -helical segments in each protein domain are shaded gray. The residues forming the binding surface observed structurally (16, 26)
or inferred by mutagenesis (12, 16, 18, 19, and this study) are boxed in red. For FADD DD, PEA-15 DED, and Tube DD, nearly the same regions
of each domain are implicated in protein-protein interaction, with the greatest degree of alignment in the portion of the loop surface at helices 5
and 6 as first identified in Tube DD (16). For Pelle DD and the CARDs of Apaf-1 and procaspase-9, the binding surfaces are divergent. Although
there is extensive overlap in structurally aligned positions of helices 2 and 3 in FADD DD and Apaf-1 CARD, Apaf-1 lacks the loop surface between
helices 5 and 6. It is this loop surface which appears to distinguish Apaf-1/procaspase-9 from Tube/Pelle modes based on these alignments. Three
additional mutants of FADD DD which suggest a juxtaposition of the Tube/Pelle and Apaf-1/procaspase-9 modes are highlighted, with asterisks
above a red box (see text).
FADD Interaction Surface for CD951480
 at UQ Library on October 11, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
803–815
7. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O’Rourke, K., Shevchenko, A.,
Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer,
P. H., Peter, M. E., and Dixit, V. M. (1996) Cell 85, 817–827
8. Medema, J. P., Scaffidi, C., Kischkel, F. C., Shevchenko, A., Mann, M., Kram-
mer, P. H., and Peter, M. E. (1997) EMBO J. 16, 2794–2804
9. Wang, J., Chun, H. J., Wong, W., Spencer, D. M., and Lenardo, M. J. (2001)
Proc. Natl. Acad. Sci. U. S. A. 98, 13884–13888
10. Kischkel, F. C., Lawrence, D. A., Tinel, A., LeBlanc, H., Virmani, A., Schow, P.,
Gazdar, A., Blenis, J., Arnott, D., and Ashkenazi, A. (2001) J. Biol. Chem.
276, 46639–46646
11. Eberstadt, M., Huang, B., Chen, Z., Meadows, R. P., Ng, S. C., Zheng, L.,
Lenardo, M. J., and Fesik, S. W. (1998) Nature 392, 941–945
12. Jeong, E. J., Bang, S., Lee, T. H., Park, Y. I., Sim, W. S., and Kim, K. S. (1999)
J. Biol. Chem. 274, 16337–16342
13. Berglund, H., Olerenshaw, D., Sankar, A., Federwisch, M., McDonald, N. Q.,
and Driscoll, P. C. (2000) J. Mol. Biol. 302, 171–188
14. Huang, B., Eberstadt, M., Olejniczak, E. T., Meadows, R. P., and Fesik, S. W.
(1996) Nature 384, 638–641
15. Liepnish, E., Ilag, I. L., Otting, G., and Iban˜ez, C. F. (1997) EMBO J. 16,
4999–5005
16. Xiao, T., Towb, P., Wasserman, S. A., and Sprang, S. R. (1999) Cell 99, 545–555
17. Sukits, S. F., Lin, L.-L., Hsu, S., Malakian, K., Powers, R., and Xu, G-Y. (2001)
J. Mol. Biol. 310, 895–906
18. Hill, J. M., Vaidyanathan, H., Ramos, J. W., Ginsberg, M. H., and Werner,
M. H. (2002) EMBO J. 21, 6494–6504
19. Bang, S.-H., Jeong, E.-J., Kim, I.-K., Jung, Y.-K., and Kim, K.-S. (2000) J. Biol.
Chem. 275, 36217–36222
20. Park, A., and Baichwal, V. R. (1996) J. Biol. Chem. 271, 9858–9862
21. Harbury, P. B., Alber, T., and Kim, P. S. (1994) Nature 371, 80–83
22. Jaattela, M., Benedict, M., Tewari, M., Shayman, J. A., and Dixit, V. M. (1995)
Oncogene 10, 2297–2305
23. Fesik, S. W. (2000) Cell 103, 273–282
24. Tartaglia, L. A., Ayres, T. M., Wong, G. H., and Goeddel, D. V. (1993) Cell 74,
845–853
25. Telliez, J. B., Xu, G. Y., Woronicz, J. D., Hsu, S., Wu, J. L., Lin, L., Sukits, S. F.,
Powers, R., and Lin, L. L. (2000) J. Mol. Biol. 300, 1323–1333
26. Qin, H., Srinivasula, S. M., Wu, G., Fernandes-Alnemri, T., Alnemri, E. S., and
Shi, Y. (1999) Nature 399, 549–557
27. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J.,
Debatin, K.-M., Krammer, P. H., and Peter, M. E. (1998) EMBO J. 17,
1675–1687
28. Siegel, R. M., Martin, D. A., Zheng, L., Ng, S. Y., Bertin, J., Cohen, J., and
Lenardo, M. J. (1998) J. Cell Biol. 141, 1243–1253
29. Garvey, T. L., Bertin, J., Siegel, R. M., Wang, G. H., Lenardo, M. J., and Cohen,
J. I. (2002) J. Virol. 76, 697–706
30. Vaughn, D. E., Rodriguez, J., Lazebnik, Y., and Joshua-Tor, L. (1999) J. Biol.
Chem. 293, 439–447
31. Weber, C. H., and Vincenz, C. (2001) FEBS Lett. 492, 171–176
32. Holm, L., and Sander, C. (1993) J. Mol. Biol. 233, 123–138
FADD Interaction Surface for CD95 1481
 at UQ Library on October 11, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Supplementary Material
Figure A:  Viability of cultured cells 24 hr following expression of FADD or FADD
mutant in CD95-stimulated  MCF7-Fas cells.  The histogram illustrates the % viable
cells as determined by cell morphology and Hoechst staining of nuclei 24 hr after
transfection with an expression plasmid for FADD or FADD mutant and stimulation with
anti-CD95 as described in Methods.  Error bars represent one standard deviation from
triplicate counts of approximately 100 cells each.
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